CARE Ratings Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter

The CARE Ratings Q2 results FY27 announcement is the next scheduled earnings event for CARE Ratings Ltd., CARE Ratings Ltd is a credit rating agency that assesses the creditworthiness of companies, banks and debt instruments across India.. The stock traded at Rs 1,649.10 on the NSE on 17 September 2026, down 0.21% from the previous close of Rs 1,652.50, about 10.3% below its 52-week high of Rs 1,838.00 and 18.4% above its 52-week low of Rs 1,392.70.

What makes the CARE Ratings Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 136.00 crore of revenue and a profit of Rs 57.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 112.00 crore and a profit of Rs 33.00 crore. Everything below is built from those reported figures rather than from any forecast.

Click Here – Get Free Investment Predictions

When Is the CARE Ratings Q2 Results FY27 Date?

The CARE Ratings Q2 results date for FY27 is not confirmed. As of 17 September 2026, CARE Ratings Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.

Also read – Nazara Technologies Q2 Results FY27 Preview: Results Date, Expectations

What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the CARE Ratings Q2 results date becomes public through that filing rather than through any advance announcement.

The CARE Ratings Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for CARE Ratings.

CARE Ratings Q2 Results Expectations: What the Market Is Actually Tracking

No verified analyst estimate for the CARE Ratings Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for CARE Ratings. The CARE Ratings Q2 results watchlist below is built from what the company has actually reported and disclosed.

CARE Ratings Q2 results are drawing attention ahead of the September 2026 quarter because the ratings agency's revenue and profit have shown a consistent seasonal pattern over the last five quarters rather than any sign of stress. Revenue moved from Rs 94 crore in Jun25 to a stronger Rs 136 crore in Sep25, then Rs 112 crore in Dec25, Rs 131 crore in Mar26 and Rs 112 crore in Jun26, while net profit followed a similar rhythm, from Rs 26 crore in Jun25 up to Rs 57 crore in Sep25, Rs 37 crore in Dec25, Rs 53 crore in Mar26 and Rs 33 crore in Jun26. This pattern, where the September quarter tends to be the strongest of the year, is the main reason the CARE Ratings Q2 results for the September 2026 quarter are being watched with a degree of optimism built on precedent rather than speculation.

Operating margin has stayed strong throughout, ranging from 30% in Jun25 to a peak of 50% in Sep25, then settling between 31% and 46% in the following quarters, reflecting the largely fixed-cost, high-margin nature of a ratings business. Return on equity of 19.7% and return on capital employed of 26.3% are both comfortably healthy figures, indicating efficient use of capital rather than reliance on debt to generate returns. Credit rating agencies as a sector tend to benefit when corporate bond issuance and bank credit growth are strong, and CARE Ratings' consistent margin profile across the last five quarters suggests the company has been a steady beneficiary of that activity rather than an outlier within the sector. This is one reason the CARE Ratings Q2 results tend to be read alongside broader credit market activity rather than in isolation.

Also read – Premier Energies Q2 Results FY27 Preview: Results Date, Expectations

Putting the numbers together, the run-up to the September 2026 quarter looks like a continuation of an established pattern rather than a departure from it, with revenue, margin and profit all moving within familiar ranges over the last five quarters. The CARE Ratings Q2 results for the September 2026 quarter will be measured against the Sep25 quarter's stronger Rs 136 crore revenue and Rs 57 crore net profit, given the seasonal tendency for the September period to outperform the surrounding quarters.

Check CARE Ratings Ltd. Live Fundamentals on the Univest Screener

CARE Ratings Q2 Results Preview: The Q1 FY27 Actuals It Builds On

CARE Ratings Ltd. reported revenue of Rs 112.00 crore in Q1 FY27, up 19.15% from Rs 94.00 crore in Q1 FY26, and a profit of Rs 33.00 crore at the net level, up 26.92% from Rs 26.00 crore in Q1 FY26. These are reported actuals, not estimates.

Sequentially, revenue was down 14.50% over the March 2026 quarter figure of Rs 131.00 crore, and net profit was down 37.74% from Rs 53.00 crore in Q4 FY26. Operating margin stood at 30.0% in Q1 FY27 against 50.0% in the September 2025 quarter, which is the comparison the CARE Ratings Q2 results print will be read against.

Q2 FY26 Base: The Comparison CARE Ratings Q2 Results FY27 Must Beat

CARE Ratings Ltd. reported revenue of Rs 136.00 crore and a profit of Rs 57.00 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this CARE Ratings Q2 results preview.

Net profit in that base quarter was above the Rs 33.00 crore just reported for Q1 FY27, so the year-on-year comparison starts from a demanding level. Revenue of Rs 136.00 crore sits above the Rs 112.00 crore of the June 2026 quarter, which frames how much sequential movement the CARE Ratings Q2 results print needs to show growth.

CARE Ratings Quarterly Results Trend Over the Last Four Quarters

Quarter	Revenue (Rs Cr)	Net Profit (Rs Cr)
Q2 FY26 (Sep 2025)	136.00	57.00
Q3 FY26 (Dec 2025)	112.00	37.00
Q4 FY26 (Mar 2026)	131.00	53.00
Q1 FY27 (Jun 2026)	112.00	33.00

Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company's exchange filings, and they are the only basis this CARE Ratings Q2 results preview uses.

Revenue across those four quarters ranged from Rs 112.00 crore to Rs 136.00 crore, and net profit from Rs 33.00 crore to Rs 57.00 crore. That spread is the honest context for the CARE Ratings Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.

Key Factors That Could Shape CARE Ratings Q2 Results FY27

The CARE Ratings Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what CARE Ratings has already reported.

Seasonal Strength In The September Quarter

Sep25 was the strongest quarter in the trailing five-quarter window for both revenue and operating margin, and this seasonal pattern is central to how the CARE Ratings Q2 results for the September 2026 quarter are likely to be assessed. If that pattern repeats, both revenue and margin could again come in above the levels seen in the adjacent Jun26 and Dec25 quarters. Watching how the CARE Ratings Q2 results compare with Sep25 will be the clearest single test of that seasonal thesis.

Consistent Profitability

Net profit has stayed positive and healthy in every one of the last five quarters, ranging from Rs 26 crore to Rs 57 crore, without a single loss-making period. This consistency is a key reason the CARE Ratings Q2 results have not raised concerns about earnings quality or volatility in the way some other names in this batch have.

Return Ratios And Sector Position

A return on equity of 19.7%, return on capital employed of 26.3% and a modest debt-to-equity ratio around 0.03 point to a capital-light, high-return business model typical of ratings agencies. As the CARE Ratings Q2 results for the September 2026 quarter approach, these return ratios provide the backdrop against which any change in revenue or margin will be judged.

CARE Ratings Q2 Results FY27: Share Price and Valuation Going Into the Print

CARE Ratings share price today is Rs 1,649.10 on the NSE, down Rs 3.40 or 0.21% from the previous close of Rs 1,652.50 on 17 September 2026, ahead of the CARE Ratings Q2 results announcement.

Metric	Value (17 September 2026)
NSE Symbol	CARERATING
Current Market Price	Rs 1,649.10
52-Week High	Rs 1,838.00
52-Week Low	Rs 1,392.70
Market Capitalisation	Rs 4967 crore
PE Ratio	27.99
PB Ratio	5.32
EPS (TTM)	Rs 58.91
Book Value per Share	Rs 310.00
Debt to Equity	0.03
Return on Equity	19.7%
50-Day Moving Average	Rs 1671.69
200-Day Moving Average	Rs 1559.62
RSI (14)	52.36

The stock trades below its 50-day average of Rs 1671.69 but above its 200-day average of Rs 1559.62, with a 14-day RSI of 52.36. None of this is a view on where the shares go once the CARE Ratings Q2 results are announced, and no price target is offered here.

Download the Univest iOS App or Univest Android App to track CARE Ratings Ltd. live price and quarterly earnings updates.

What Investors Should Watch When CARE Ratings Q2 Results Are Announced

Four lines carry most of the information in a company of this size, and reading them in order keeps the CARE Ratings Q2 results print in proportion.

1. Revenue against the Rs 136.00 crore reported in the September 2025 base quarter
2. Net profit against a profit of Rs 57.00 crore in that same quarter
3. Operating margin against 30.0% in Q1 FY27
4. Any exceptional item, provision or one-off gain disclosed alongside the numbers

A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the CARE Ratings Q2 results announcement should be read together with the notes to the results rather than the headline alone.

Conclusion on CARE Ratings Q2 Results FY27

The CARE Ratings Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. CARE Ratings Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.

On that basis the CARE Ratings Q2 results FY27 print faces a base of Rs 136.00 crore in revenue and a profit of Rs 57.00 crore, with the most recent quarter having delivered Rs 112.00 crore and a profit of Rs 33.00 crore. No numerical estimate appears in this preview because no verified consensus figure exists for CARE Ratings, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.

FAQs on CARE Ratings Q2 Results FY27

What is the CARE Ratings Q2 results date for FY27?

Ans. The CARE Ratings Q2 results date for FY27 is not confirmed. CARE Ratings Ltd. had not filed a board meeting intimation with the NSE or BSE as of 17 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.

What quarter do the CARE Ratings Q2 results 2026 cover?

Ans. The CARE Ratings Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. CARE Ratings Ltd. reports revenue, operating profit and net profit for that period, and the CARE Ratings Q2 results filing also carries the notes to the accounts.

What were the CARE Ratings Q1 FY27 results?

Ans. CARE Ratings Ltd. reported revenue of Rs 112.00 crore in Q1 FY27 and a profit of Rs 33.00 crore at the net level. Revenue was up 19.15% versus Q1 FY26 and net profit was up 26.92% from Rs 26.00 crore in Q1 FY26.

What were CARE Ratings Q2 FY26 results in the September 2025 quarter?

Ans. CARE Ratings Ltd. reported revenue of Rs 136.00 crore and a profit of Rs 57.00 crore in Q2 FY26. Operating margin was 50.0%. Those figures form the base for the CARE Ratings Q2 results FY27 comparison.

What are the main CARE Ratings Q2 results expectations this quarter?

Ans. No verified analyst estimate is publicly available. The CARE Ratings Q2 results expectations centre on revenue against the Rs 136.00 crore base, net profit against a profit of Rs 57.00 crore, operating margin against 30.0% in Q1 FY27, and any exceptional item disclosed with the numbers.

What is CARE Ratings share price today ahead of the Q2 earnings?

Ans. CARE Ratings share price is Rs 1,649.10 on the NSE as of 17 September 2026, down 0.21% from Rs 1,652.50. The stock is about 10.3% below its 52-week high of Rs 1,838.00 and 18.4% above its 52-week low of Rs 1,392.70, at a market capitalisation of Rs 4967 crore.

Is CARE Ratings a good stock to buy before the Q2 results?

Ans. This article does not offer a buy, sell or hold recommendation on CARE Ratings Ltd. The stock trades at a price-to-book ratio of 5.32 with a return on equity of 19.7%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.